News
One such therapy, called “grounding” or “earthing,” involves reconnecting with the Earth’s energy by standing barefoot on natural surfaces. While it may sound simple, the practice is now ...
"This partnership marks an important milestone for Creyon as we work to advance our RNA-targeted oligo therapy pipeline to the clinic for both rare and common diseases." “We are pleased to ...
Persistence has paid off for Abeona Therapeutics and its gene therapy for recessive dystrophic epidermolysis bullosa (RDEB). About a year after the FDA rejected the company's prior approval filing ...
GIZ943, also known as [177Lu] Lu-EVS459, is a radioligand therapy that targets cells that express folate receptor alpha (FRα). The spokesperson said Novartis stopped development “based on an ...
April 29 (Reuters) - The U.S. Food and Drug Administration approved Abeona Therapeutics' (ABEO.O), opens new tab gene therapy for a rare skin disorder on Tuesday. The gene therapy, called Zevaskyn ...
The Food and Drug Administration on Tuesday approved a new treatment for a rare skin condition, teeing up a commercial battle between two cell and gene therapy developers. The agency cleared Abeona ...
Using rare natural human immune components developed within a legally protected secret substance, the patented therapy is the first of its type, according to Al-Salihi. The Iraqi scientist ...
Actor Paresh Rawal has said he drank his urine for 15 days to recover from knee pain, making a case for urine therapy, urophagia or urotherapy. During an interview with Lallantop’s Saurabh Dwivedi, he ...
And when you guys forced me to go to therapy afterwards.” Schroeder asked why everyone in her life wanted to “push therapy” on her. While the reality star didn’t offer too many details on ...
As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene therapy space, experts express wariness over the unknowns and optimism that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results